Range
12.94 - 13.97
Vol / Avg.
62K/150.8K
Div / Yield
-
52 Wk
11.4 - 29.43
Mkt Cap
339.5M
Payout Ratio
-
Open
13.39
P/E
-
EPS
-0.25
Shares
24.4M
Outstanding
24.4M
Total Float
13M

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-16
REV
Q2 2021Est.ActualSurprise
EPS-0.160-23.800 -23.6400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aerovate Therapeutics Questions & Anwsers

Q

How do I buy Aerovate Therapeutics (AVTE) stock?

A

You can purchase shares of Aerovate Therapeutics (NASDAQ: AVTE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aerovate Therapeutics's (AVTE) competitors?

A

There are no as such competitors for Aerovate Therapeutics.

Q

What is the target price for Aerovate Therapeutics (AVTE) stock?

A

The latest price target for Aerovate Therapeutics (NASDAQ: AVTE) was reported by Evercore ISI Group on July 26, 2021. The analyst firm set a price target for 30.00 expecting AVTE to rise to within 12 months (a possible 115.67% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aerovate Therapeutics (AVTE)?

A

The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $13.91 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Aerovate Therapeutics (AVTE) pay a dividend?

A

There are no upcoming dividends for Aerovate Therapeutics.

Q

When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?

A

Aerovate Therapeutics’s $Q3 earnings are confirmed for after-market on $November 16, 2021.

Q

Is Aerovate Therapeutics (AVTE) going to split?

A

There is no upcoming split for Aerovate Therapeutics.

Q

What sector and industry does Aerovate Therapeutics (AVTE) operate in?

A

Aerovate Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.